Background: In a planned International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) worldwide study on reference intervals (RIs), a common panel of serum samples is to be measured by laboratories from different countries, and test results are to be compared through conversion using linear regression analysis. This report presents a validation study that was conducted in collaboration with four laboratories. Methods: A panel composed of 80 sera was prepared from healthy individuals, and 45 commonly tested analytes (general chemistry, tumor markers, and hormones) were measured on two occasions 1 week apart in each laboratory. Reduced major-axis linear regression was used to convert reference limits ( LL and UL ). Precision was expressed as a ratio of the standard error of converted LL or UL to the standard deviation (SD) comprising RI (approx. 1/4 of the RI width corresponding to between-individual SD). The allowable and optimal levels of error for the SD ratio (SDR) were set as ≤ 0.250 and ≤ 0.125, respectively, in analogy to the common method of setting limits for analytical bias based on between-individual SD. 
PSA, prostate-specific antigen; PTH, intact parathyroid hormone; RI, reference interval; RMP, reference measurement procedure; SD G , between-individual SD; SD I , withinindividual SD; SD RI , SD comprising RI ( )
Introduction
Plans for a worldwide multicenter study on reference values were developed progressively since 2010 by the Committee on Reference Values and Decision Limits (C-RIDL) of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), with the participation of the USA, the UK, Turkey, Japan, China, Saudi Arabia, India, South Africa, and the Philippines. Its objectives are (1) to establish country-specific RIs from 500 or more healthy individuals in a harmonized manner using a common protocol (2) to make test results comparable across participating countries through the common measurement of a specified panel of sera on the basis of linear regression analysis, and (3) to explore sources of variation of the aligned test results using information obtained from a questionnaire given to each individual in the pool. The detailed protocol, standard operating procedures (SOPs) and the questionnaire to be used for subject recruitment, sample collection, specimen processing, measurements, and data analysis have been discussed in the companion paper [ 1 ] . The schemes for implementing the adopted study were as follows: 1. Each country will conduct its own multicenter study to derive country-specific RIs and explore sources of variation of the test results relevant to that country. The target analytes and questionnaire items, which are not included in the general protocol, can be varied according to local needs for the survey. 2. Collaborating local laboratories in each country will recruit appropriate healthy volunteers and collect and process specimens as per the SOPs. 3. A centralized measurement scheme will be used to eliminate variation attributable to differences in analytical methods. One laboratory (or two) will act as a central laboratory in each country, receive specimens from local laboratories, and carry out collective measurement. The central laboratory can use any assay platform.
4. For standardized analytes, it is requested that the laboratory ensure that RIs are traceable to the RMPs for standardized analytes through the measurement of certified reference materials (CRMs) or value-assigned sera provided by reference laboratories listed by the Joint Committee for Traceability in Laboratory Medicine. 5. For non-standardized analytes, RIs determined centrally will be converted to those of each participating laboratory based on the results of local comparative measurements (cross-check testing) using aliquots of the specimens taken for the study. 6. For worldwide comparison, test results will be made comparable across the collaborating countries by the measurement of the same panel of sera by all laboratories.
Among these various schemes, the successful alignment of test results among countries is of utmost importance to allow the comparison of country-or region-specific reference intervals (RIs). This will depend largely on the reliability of the comparison of test results on the panel of sera.
In this study, a panel of sera from 80 healthy volunteers was freshly prepared and then distributed to four reference laboratories in Turkey, Japan, and the US (two sites). All samples were assayed twice in each laboratory, 1 week apart, for 45 commonly tested analytes (general chemistry and immunoassays). The practicability of converting test results or RIs from one laboratory to another was evaluated based on variability of the slope and converted reference limits as a function of the required sample size in the panel.
Materials and methods

Preparation of the panel of sera
Recruitment of healthy volunteers
With the approval of the Ethical Committee in Yamaguchi University Graduate School of Medicine, healthy volunteers were recruited mainly from the hospital ' s health workers. Only subjects who were between 20 and 65 years old and who were subjectively healthy were included in the study. Excluded were those who were anemic, overweight (BMI > 30), known to have hyperlipidemia, known to be a carrier of HBV, HCV, or HIV, pregnant or had given birth within 1 year, heavy drinkers (ethanol > 70 g/day on average), heavy smokers ( ≥ 25 cigarettes/day), or taking more than three drugs on a regular basis for a chronic disease.
A total of 80 healthy volunteers agreed to donate blood for producing the panel aft er the objectives, precautions about sampling of a large volume of blood, and benefi ts of participation (free testing of 45 analytes listed below) had been explained to them. Written consent was obtained from each volunteer before participation in the study.
Blood collection and specimen preparation
Aft er overnight fasting, blood was drawn using 19-gauge butterfl y needles and 55-mL disposable syringes with total draws of 220 mL from male subjects and 180 mL from female subjects. Each tube of blood was transferred into a large conical centrifuge tube with 45-mL capacity. Then, the conical tubes were left at room temperature for 60 min and centrifuged at room temperature for 10 min at 1200 g . The serum was poured into a glass beaker with 200-mL capacity. Aft er thorough mixing, the serum, with a total volume of approximately 90 mL, was aliquoted with equal volumes of 1.5 mL into 1.8-mL capacity CryoTube cryovials (Nunc, Roskilde, Denmark). Thus, 60 or more serum aliquots were obtained from each volunteer. They were immediately stored in a freezer at − 80 ° C. Single serum aliquots from each of the 80 individuals were assembled into 80-member panel sets, and 60 of these sets were placed into 60 individual freeze boxes for distribution to the participating sites.
Collaborating laboratories and target analytes
Four sets of samples were transported at − 80 ° C to each of the following four collaborating laboratories: Central Clinical Laboratory of Mayo Clinic in Rochester, MN, USA; ARUP Laboratories in Salt Lake City, UT, USA; Clinical Laboratory of Uludag University Hospital, Bursa, Turkey; Beckman Coulter Japan ' s Mishima Central Laboratory, Mishima, Japan. Two sets were to be used to assay analytes by chemical assays and immunoturbidimetry and two for testing other analytes by immunoassay methods.
The following 45 analytes in each serum were measured: total protein (TP), albumin (Alb), urea nitrogen (UN), uric acid (UA), creatinine (CRE), total bilirubin (TBil), sodium (Na), potassium (K), chloride (Cl), calcium (Ca), inorganic phosphate (IP), iron (Fe), glucose (Glu), total cholesterol (TCho), triglycerides (TG), HDL-cholesterol (HDL-C), LDL cholesterol (LDL-C), AST, ALT, ALP, LDH, GGT, CK, amylase (AMY), complement components 3 and 4 (C3 and C4, respectively), transferrin (Tf), transthyretin (TTR), vitamin B12 (VB12), folate, ferritin, AFP, CEA, CA19-9, CA125, PSA, prolactin (PRL), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2), thyrotropin (TSH), free thyroxine (FT4), free triiodothyronine (FT3), intact parathyroid hormone (PTH), and insulin.
The assay platforms and methods used in each laboratory are as listed in Table 1 .
Assay procedures and quality control
All 80 sera in the panel were separated into two to four parts and measured in singleton on two diff erent days to evaluate the between-day variation. The measurements were repeated using the second set of samples 1 week later, using the same schedule, to determine the reproducibility of test results. During the assay, a minipanel, consisting of fi ve deep-frozen sera prepared from fi ve of the healthy volunteers, was measured each day in singleton to monitor the stability of the assay over the study period. In addition, to confi rm the status of standardization of the assays in each laboratory, the following CRMs with assigned values, all supplied as sets of vials containing deeply frozen specimens, were purchased from the Reference Material Institute for Clinical Chemistry Standards (ReCCS), Japan: JCCRM224-5a for HDL-C, LDL-C, TCho, and TG consisted of one set of four reference materials to be measured in triplicate in a single day; JCCRM321-5 for UA, CRE, Glu, and urea consisted of two sets of three materials with diff erent levels of these analytes to be measured on two separate days each in triplicate; JCCRM521-10 for Na, K, Cl, Ca, Mg, and IP consisted of three sets of two materials to be measured on three separate days, each day in triplicate.
Data analysis
Cross-comparison of test results among laboratories
There are a variety of ways for expressing the linear functional relationship of test results between any two laboratories [ 2 -7 ] . Principal component regression (PCR) requires the assumption that the slope of the regression line equals 1.0 and the use of equivalent scales and units of measurement in both laboratories for use in method comparison, whereas reduced major axis regression (MAR) does not require these assumptions [ 2 , 3 ] . Deming regression (DR) [ 7 ] overcomes the problem of PCR by introducing an error ratio ( λ ) of test results of one laboratory to the other. However, determining λ requires replicate measurements of each specimen in both laboratories. Therefore, the most appropriate and generally applicable method of regression for the purpose of this study was MAR [ 2 ] . It is also known as geometric mean regression [ 6 ] or least-square product regression [ 2 ] and is expressed as follows, with y , x , and b denoting the means of x (test results from laboratory X), y (corresponding results from laboratory Y), and the slope, respectively:
Slope b is determined by the following formula:
, ,
where n, S xx , and S yy denote the sample size and sums of squared deviations of values from laboratories X and Y, respectively. Using the regression equation (1), the lower limit ( LL 0 ) and upper limit ( UL 0 ) of an RI derived using test results ( x ) of laboratory X can be converted to those of laboratory Y ( LL and UL ) using the following formulae:
The precision of the conversion can be evaluated from the magnitude of standard error (SE) of the slope
, where the SE in this context implies standard deviation (SD) of any summary value X (statistics, such as b, r, LL, UL ).
Assuming equal variance of the data points (homoscedasticity) around the regression line for the range of regression and an equal ratio of inherent errors on both x and y, SE ( b ) can be computed by the following formula using Pearson correlation coeffi cient r and the data size n. This formula has not been described in the past Table 1 List of analytes and assay platforms for comparative measurements. 
and SE ( UL ) can also be calculated theoretically using the formulae shown in Appendix B by specifying x = LL 0 and x = UL 0 , respectively, together with well-known parameters of linear regression analysis: r , n, SD of the observed x ( s x ), and SD around regression line computed by the ordinary least-squares method ( s LS , oft en denoted as s y , x ). The computed values of the precision parameters CV( b), SE ( LL ), and SE ( UL ) were compared with those obtained empirically by the conventional method using the bootstrap method To standardize the variability of SE ( LL ) or SE ( UL ), we considered two methods. One is to take its ratio to the SD comprising RI ( SD RI ), and we designated it as the SD ratio (SDR) of LL or UL ( SDR LL and SDR UL , respectively) ( Figure 2 
Figure 2
The concept of SDR as a measure of precision for converting the RI. The RI determined by laborator X ( LL 0 -UL 0 ) is converted to that of laboratory Y as LL -UL using the reduced major-axis regression line. To avoid the infl uence of outlying points in the regression, the SD of data points along the minor axis of the ellipse ( SD Min ) perpendicular to the regression line was computed, and any point four times SD Min or more away from the center along the minor axis was excluded from the computation.
When the distribution of observed test results deviates from a Gaussian distribution, the theoretically derived CV( b), SDR LL , and SDR UL can be biased partly due to heteroscedasticity of data points around the regression line (more scattering of data points toward the tail of the distribution). To examine the eff ect of Gaussian transformation on the regression statistics, we chose the following analytes whose values usually show a distribution with a long right tail: TBil, Glu, TG, AST, ALT, LD, GGT, CK, Tf, VB12, AFP, CEA, CA19-9, CA125, PSA, estradiol, PRL, LH, FSH, TSH, FT4, and insulin.
SDR LL or SDR UL based on the regression line derived aft er logarithmic (log) transformation can be computed from LL, UL, SE ( LL ), and SE ( UL ) using the following formulae involving exponential function for back-transformation, where LL T and UL T represent LL 0 and UL 0 converted using the regression line and y and x represent the averages of log( x ) and log( y ) for all data points. ) is used to convert the distribution of test values into the Gaussian form, the above formulae should be modifi ed at the back-transformation step using the value to the power of 1/ p .
Resampling studies for evaluating the minimum sample size required for the panel
For each of the pairwise comparisons among the four laboratories, consisting of 80 pairs of test results, a subset of the results with data size of 20, 30, 40, 50, 60, or 70 was randomly sampled with replacement, and CV( b), SDR LL , and SDR UL were computed by reduced MAR. In any case, the LL 0 and UL 0 required for computing LL and UL were fi xed to the mean ± 1.96 SD derived from all test results (n = 80) of laboratory X.
Results
Analytical variations
The analytical CV ( CV A ) listed in Supplementary Table 1 , which accompanies the article at http://www.degruyter. com/view/j/cclm.2013.51.issue-5/issue-files/cclm.2013.51. issue-5.xml, was computed for each analyte from the results of repeated measurements of the same panel done in each of the four laboratories. It represents the proportion of an average SD of 80 data points to the grand mean (GM) of all observations, which corresponds to coarse between-day CV of test results, including the component of within-day CV. The observed magnitude of CV A for almost all analytes was well below 0.75 (Δ), 0.5 ( ○ ), or 0.25(•) times the within-individual CV ( CV I ), as reported by Fraser [ 9 ] , regarded as the thresholds of minimal, desirable, and optimal levels of error, respectively. CV A above the allowable limit ( > 0.75 × CV I ) was found for Na, Cl, Ca, estradiol, FSH, and FT4 in some laboratories.
The assay precision of each analyte was also analyzed from the test results of quality control sera measured concurrently over the study period. The results are summarized in Supplementary Table 2 . Among the standardized analytes, we regarded Na, Cl, and Ca as difficult analytes for keeping the precision within acceptable levels. As for the nonstandardized analytes (mostly immunoassays), fairly large between-day variations were observed for ferritin, CA19-9, and FT4. However, for other analytes, we regarded the reproducibility as excellent, considering the inherent variability of immunoassays, with their CV A well below CV I × 0.5. -The reproducibility of two measurements obtained over a 1-week period within the same laboratory is excellent by visual inspection except for those of Na, Cl, CA19-9, FT4, and FT3 for which a large scatter around the regression lines was observed. -The regression lines drawn between the results from any two laboratories were very close to y = x for almost all of the standardized analytes except for those showing variable degrees of bias, judging from a wide range of slopes (cf. Table 2) , such as Na, Cl, Ca, HDL-C, LDL-C, ALP, and C4. ( Table 2 Continued) -For the non-standardized analytes, regression were approximately y = x for IP, Fe, C3, AFP, CEA, CA125, and PSA, whereas variable degrees of bias were noted for ferritin, folate, VB12, CA19-9, estradiol, PRL, LH, FSH, FT4, PTH, and insulin. -Although most points are close to the regression line, a few to several outlying points were observed in the plots for CEA, CA125, folate, PRL, and insulin.
Comparison of test results across the four laboratories
Comparison of regression parameters representing the precision of converting RI Table 2 shows the summary statistics obtained from the dataset shown in Figure 3 (and Supplementary Figure 1 The correlation coefficients r were generally very high ( r > 0.95). Analytes with r < 0.9 include Alb, Na, Cl, Ca, CA19-9, FT4, and FT3, indicated by a gray background. The wider 90% range of variation of the slope b shown in column 3 implies either a lack of close correlation or the presence of between-method bias in the test results or both. The presence of both conditions implies that the conversion of test results between laboratories is not feasible.
The skewness ( Sk ) of distribution was computed from the test values of each laboratory, and the average Sk of the 4 (or 3) laboratories is shown in column 3. The distribution was regarded as nearly symmetrical when | Sk | ≤ 0.4, and values of Sk > 0.4 are shown with a gray background.
SDR LL and SDR UL , which were above the optimal (0.125) or allowable (0.25) limits, are also shown with a gray background. Analytes with either of the SDRs above the allowable limits using all test results (n = 80) include Na and CA19-9; additional analytes with either of SDRs above the optimal limits are Cl, CRP, FT4, and FT3.
The ratio of SDR UL to SDR LL shown in column 8 was noticeably higher when Sk is > 0.4. Close correlation ( r = 0.874) was observed between Sk and SDR UL / SDR LL , implying that SDRs depend on the distribution pattern. Meanwhile, it was noted that CV( b ) shows a high correlation with both SDR LL and SDR UL . Furthermore, the correlation is dependent on Sk of the distribution of test results, as shown by analyzing the correlation after stratification of 45 analytes by Sk ( Figure 4 ) . It was also found that there is a closer correlation of CV( b ) with the average of SDR LL and SDR UL (aveSDR, shown in column 7), which was less affected by Sk than was the individual SDR. The relationship between the two statistics was computed as follows using reduced MAR:
From this equation, SDRs of 0.125 (optimal limit) and 0.25 (allowable limit) was calculated as equivalent to CV( b ) of approximately 5.5% and 11%, respectively. 
Figure 4 Relationships among SDRs and CV( b ).
From the data listed in Table 2 , the relationships between CV( b ) and SDRs ( SDR LL , SDR UL , or the average of the two) were examined after partitioning the data for 45 analytes by average skewness ( Sk ) of their distributions into three groups ( | Sk | ≤ 0.4, 0.4 < Sk ≤ 0.8, and 0.8 < Sk ). The regression lines drawn were computed by reduced MAR.
the bootstrap method matches well with the calculated value from the formula. When the distribution is skewed to the higher side ( Sk > 0.4), both ratios increase in proportion to Sk . Meanwhile, b SDR LL / SDR LL is not much associated with Sk . This implies that skewness to the lower side of values does not affect the regression in estimating LL because of clustering of data to the lower side. Table 3 shows a summary of the regression line statistics obtained either with or without log transformation of results for the selected analytes. As evident from the comparison of columns 1 and 2, the skewness was greatly decreased after log transformation. CV( b ) calculated by the formula did not change much as a whole, whereas bCV( b ) empirically derived by the bootstrap method was generally decreased by the transformation, suggesting an overestimation of the variation of the slope. In contrast, SDR UL increased after the transformation, whereas b SDR UL changed very little. This phenomenon is interpreted as follows: in the former, by log transformation, the data points around LL have more influence on the regression, and thus, a wider variation occurred to the predicted UL . In the latter, a wider variation of data points around UL was reduced after log transformation, but at the same time, the variation around LL was increased, and thus, as a whole, the average b SDR UL did not change much. SDR LL is reduced after log transformation by either of the methods, indicating that both SDR LL and b SDR LL tend to be underestimated when the data are highly skewed. In any case, after log transformation of test results, as shown in columns 24 and 26, the dissociation of the two approaches in evaluating the precision of regression errors is greatly reduced. Table 3 The effect of logarithmic transformation on the regression statistics related to the precision of the method comparison. 
Effects of log transformation of the skewed distribution on the regression line statistics
Resampling study to examine the effect of data size on precision of the conversion
From the original sets of 80 test results from laboratories X and Y, a sample subset (n = 20, 30, 40, 50, 60, 70, or 80) was randomly drawn (resampled) with replacement, and the slope b by reduced MAR and converted LL 0 and UL 0 ( LL and UL ) were computed. This process was repeated 500 times, and CV( b), SDR LL , and SDR UL were computed using the theoretical formula. Table 4 summarizes the results showing the effect of sample size on three statistics of conversion. It tabulates the medians SDR LL , SDR UL , and CV( b ) of all pairwise comparisons for each data size (12 combination for analytes measured twice by three laboratories, and 24 combinations for those measured twice by four laboratories). From our criterion for an allowable level (SDR ≤ 0.25), the percentage of analytes with that level of precision does not change much for 20 ≤ n ≤ 60. Meanwhile, the percentage of analytes with the optimum level of precision (SDR ≤ 0.125) declines appreciably for n = 20. For CV( b ), applying the above-mentioned criteria [allowable CV( b ) as ≤ 11%; optimum CV( b ) as ≤ 5.5%], a similar tendency was observed to that for SDRs.
Assuming 40 sera as a practical size of the panel for use in the worldwide study, based on the allowable limits of CV( b ), the reference values of Na, Cl, CA19-9, FT4, and FT3 (or 11% of the analytes examined) were not acceptable for use in comparison across the countries. At the optimal level of CV( b ), 20% of the analytes, with the addition of TP, Alb, Ca, and CA125 to the above analytes, were regarded as not acceptable for comparison.
Discussion
The key strategy of the worldwide study on reference values is to measure a panel of sera in common and to align test results across countries on the basis of linear regression analysis. Thus, the objective of this preliminary investigation was to determine the most appropriate parameter along with its threshold value to judge its utility in converting RI among the collaborating laboratories. This study also intends to determine the most practical number of specimens (sample size, n) in the panel for use in the worldwide study.
There are several options for the statistical approach for the method comparison [ 2 -7 ] . In the field of clinical chemistry, DR [ 7 ] has generally been considered as the most rational one because it can deal with the imbalance in the inherent errors of variables x and y . However, it requires an appropriate estimate of the error ratio ( λ ), especially when x and y variables are measured in different units or scales. Therefore, a replicate measurement is expected at the time of method comparison, which is not a common laboratory practice. Nevertheless, it is not reliable to estimate λ from the CV A of each variable if not determined concurrently. Furthermore, λ is usually not constant over the range of regression. This situation necessitates the use of weighted DR [ 7 ] and proper derivation of the weighting factor, which further complicates the problem by requiring a larger number of measurements in replicate. Another downside of DR is that there is no mathematical formula to derive the SEs of the slope and other parameters. Their derivation depends on the use of the bootstrap method [ 8 ] , which may not be reliable with a small sample size.
Meanwhile, the reduced MAR [ 2 -7 ] gives the line of structural relationship equal to the reduced major axis of the ellipse delineating the scatter of data points. Its preferable property is that the regression is not influenced by the scale of measurement [ 2 , 3 ] and thus can be used for comparison of test results for non-standardized analytes measured using two different units or scales. Furthermore, the SEs of the slope and point estimation based on the regression can be mathematically derived as we demonstrated in the appendices. Therefore, we regarded MAR as a practical method of choice for the purpose of the worldwide study.
The precision of the conversion using MAR depends on the sample size n and the degree of correlation of test results from the laboratories under comparison. Both parameters are contained in the mathematical formula to derive the CV of the slope:
, derived by the bootstrap method, was used in the 2009 Asian study to judge whether it was permissible to convert the centrally derived RI to that of each local laboratory [ 10 , 11 ] . This conversion of RIs was provided as an option to the collaborating laboratories on an experimental basis. The number of sera actually measured for comparison in each local laboratory varied widely from nine to 73, with an average of 22.2. Therefore, we could not rely solely on the degree of correlation r to judge the appropriateness of converting the RI and found CV( b ) to be useful in the judgment based on the knowledge that the CV of the slope by the least-squares method is well known to reflect both r and n. We empirically set the allowable level of conversion as CV( b ) < 10%, which roughly corresponds to r > 0.96 (with n = 10), r > 0.90 (with n = 25), or r > 0.85 (with n = 40), after inspection of all results of cross-check testing between the central laboratory and 44 local laboratories with regard to the stability of the regression lines. Incidentally, the cutoff value of 10% is very close to the allowable limit set in this study for CV ( b ) computed by the mathematical formula. However, there was some criticism about judging the allowable level of conversion simply on the basis of r and n. Therefore, in this study, we also evaluated the SE of the converted reference limits LL and UL, SE ( LL ) and SE ( UL ), respectively, which were computed based on the mathematical formula we have derived in this study (see Appendix B for its proof). To standardize them, we opted to use their ratio to SD RI , which is approximately 1/4 of the width of the converted RI and corresponds to gross between-individual SD, I G
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The cutoff values for the ratios SDR LL and SDR UL were set in analogy to setting limits for analytical bias, with SDRs = SE/ SD RI ≤ 0.25 as an allowable level and SDRs = SE/ SD RI ≤ 0.125 as an optimal level [ 9 ] .
At the threshold of allowable precision ( SDR UL = 0.25), assuming a standardized Gaussian distribution of test values ( z ) and the converted RIs of LL = − 1.96 and of UL = 1.96, the 90% CI of UL is computed as z = 1.55 -2.37 (1.96 ± 1.645 × 0.25). This implies that when UL is computed as z = 1.55 as an extreme case, we would expect a 3.56% absolute increase (or 2.42-fold relative increase) in falsepositive cases using the RI: P ( z ≥ 1.55) − P ( z ≥ 1.96) = 0.0606 − 0.0250 = 0.0356 (or 0.0606/0.025 = 2.42). Similarly, the UL of z = 2.37 as an opposite case gives a 1.61% (0.0250 − 0.0089) absolute increase (2.81-fold relative increase) of falsenegative cases. At the threshold of optimal precision ( SDR UL = 0.125), the 90% CI of the UL is z = 1.75 -2.16, and thus, we would expect a 1.51% (0.0401 − 0.0250) absolute increase (1.60-fold relative increase) in false-positive cases at z = 1.75, and 0.96% (0.025 − 0.0154) absolute increase (1.62-fold relative increase) in false-negative cases at z = 2.16.
From this outcome analysis of conversion error, the use of conversions at the optimal level of precision seems better in a practical sense, giving smaller rates of misclassification in using the RI than the larger error rates associated with use of conversions at the allowable level of precision.
An important issue we found in applying SDRs in the judgment of convertibility was that SDRs depended on the distribution pattern of test results for the panel. When the test results showed a symmetrical or Gaussian distribution ( | Sk | < 0.4), SDR LL and SDR UL were equivalent, but when the distribution was skewed toward the higher values, as is commonly seen in test results for TG, ALT, or GGT, SDR UL tended to become larger relative to SDR LL . Therefore, judgment on convertibility depended solely on the value of SDR UL . 
